Virginia O. Shaffer
Quick facts
Phase 2 pipeline
- biologically active human fecal microbiota
Restores healthy gut microbiome diversity and function by introducing a complex community of beneficial microorganisms from healthy donors.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Related
- Sector hub: All tracked pharma companies